Outcome | Abstinent individuals at 12 weeks | Non-abstinent individuals at 12 weeks | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
t0 M (SD) | t3 M (SD) | p | t (df) | d | t0 M (SD) | t3 M (SD) | p | t (df) | d | |
PSS-10 | 19.25 (4.81) | 14.89 (4.22) |  < 0.001*** | 5.10 (27) | 0.97 | 18.49 (5.22) | 19.71 (5.58) | 0.176 | −1.38 (34) | – |
FFA | 2.45 (0.32) | 2.70 (0.33) |  < 0.001*** | −3.85 (27) | 0.75 | 2.66 (0.40) | 2.57 (0.34) | 0.083 | 1.79 (34) | – |
SEQ-12 | 33.83 (8.93) | 44.5 (9.74) |  < 0.001*** | −4.71 (27) | 1.14 | 31.83 (8.03) | 31.94 (8.44) | 0.951 | −0.06 (34) | – |
L-1 | 5.57 (1.57) | 7.14 (1.43) |  < 0.001*** | −3.75 (27) | 1.05 | 6.20 (1.62) | 5.89 (1.98) | 0.324 | 1 (34) | – |
SF12 PH | 16.21 (2.08) | 17.42 (1.45) | 0.005** | −3.06 (27) | 0.68 | 16.03 (2.39) | 16.49 (2.42) | 0.222 | −1.24 (34) | – |
SF12 MH | 18.79 (3.37) | 20.82 (2.76) | 0.011* | −2.75 (27) | 0.66 | 18.95 (3.15) | 18.49 (4.37) | 0.475 | 0.72 (34) | – |
 | Abstinent individuals at 24 weeks | Non-abstinent individuals at 24 weeks | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | t0 M (SD) | t4 M (SD) | p | t (df) | d | t0 M (SD) | t4 M (SD) | p | t (df) | d |
PSS-10 | 18.83 (4.98) | 13.38 (4.97) |  < 0.001*** | 4.45 (22) | 1.01 | 18.77 (5.39) | 18.81 (5.76) | 0.974 | −0.03 (30) | – |
FFA | 2.49 (0.31) | 2.78 (0.35) |  < 0.001*** | −3.55 (22) | 0.85 | 2.61 (0.42) | 2.65 (0.38) | 0.499 | −0.68 (30) | – |
SEQ-12 | 32.30 (7.81) | 50.17 (9.77) |  < 0.001*** | −7.63 (22) | 2.02 | 33.35 (9.57) | 28.74 (6.76) | 0.035* | 2.21 (30) | 0.56 |
L-1 | 5.61 (1.73) | 7.83 (1.40) |  < 0.001*** | −4.89 (22) | 1.41 | 6.06 (1.59) | 6.35 (2.33) | 0.521 | −0.65 (30) | – |
SF12 PH | 16.22 (2.26) | 17.74 (1.36) | 0.002** | −3.46 (22) | 0.82 | 16.06 (2.05) | 16.26 (2.54) | 0.579 | −0.56 (30) | – |
SF12 MH | 18.91 (3.68) | 22.57 (2.48) |  < 0.001*** | −4.47 (22) | 1.16 | 18.55 (3.15) | 19.55 (4.06) | 0.118 | −1.61 (30) | – |